The current valuation score of Arbutus Biopharma Corp is 8.62, ranking 79 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 5.23, which is 20.28% below the recent high of 6.29 and 615.96% above the recent low of -26.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.